
Global Health Investment Fund (GHIF)
North America, New York, United States, New York
Description
Impact investment fund established to finance late-stage development of new drugs, vaccines and diagnostics for public health challenges
Investor Profile
Global Health Investment Fund (GHIF) has backed more than 17 startups, with 0 new investments in the last 12 months alone. The firm has led 6 rounds, about 35% of its total and boasts 7 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series Unknown, Series C rounds (top funding stages).
- Majority of deals are located in United States, Austria, Australia.
- Strong thematic focus on Biotechnology, Health Care, Medical Device.
Stage Focus
- Series B (18%)
- Series Unknown (18%)
- Series C (18%)
- Series A (12%)
- Post Ipo Equity (12%)
- Series D (6%)
- Seed (6%)
- Debt Financing (6%)
- Post Ipo Debt (6%)
Country Focus
- United States (53%)
- Austria (12%)
- Australia (12%)
- India (6%)
- United Kingdom (6%)
- South Korea (6%)
- Belgium (6%)
Industry Focus
- Biotechnology
- Health Care
- Medical Device
- Medical
- Manufacturing
- Clinical Trials
- Life Science
- Biopharma
- Health Diagnostics
- Non Profit
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Global Health Investment Fund (GHIF) frequently co-invest with?
Which angels does Global Health Investment Fund (GHIF) often collaborate with?
What are some of recent deals done by Global Health Investment Fund (GHIF)?
Find More Investors Like Global Health Investment Fund (GHIF)
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides










